NCT04123886 2022-05-06A Phase I Study Evaluating SCB-313(Recombinant Human TRAIL-Trimer Fusion Protein) for the Treatment of Malignant Pleural EffusionSichuan Clover Biopharmaceuticals, Inc.Phase 1 Completed14 enrolled
NCT03869697 2022-02-02Study With SCB-313 (Recombinant Human TRAIL-Trimer Fusion Protein) for Treatment of Malignant Pleural EffusionsClover Biopharmaceuticals, LtdPhase 1 Completed5 enrolled
NCT01327235 2014-08-01Endostar and/or Cisplatin for Treatment of Malignant Pleural Effusion or AscitesJiangsu Simcere Pharmaceutical Co., Ltd.Phase 2 Completed336 enrolled
NCT02191540 2014-07-23Efficacy and Safety Study of Abnoba Viscum F 20mg in Malignant Pleural Effusion PatientsAbnoba KoreaPhase 3 Completed68 enrolled